tradingkey.logo
tradingkey.logo
Search

Embecta Corp

EMBC
Add to Watchlist
3.350USD
-0.010-0.30%
Close 07/02, 13:00ETQuotes delayed by 15 min
198.75MMarket Cap
1.75P/E TTM

More Details of Embecta Corp Company

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Embecta Corp Info

Ticker SymbolEMBC
Company nameEmbecta Corp
IPO dateMar 21, 2022
CEOKurdikar (Devdatt)
Number of employees1850
Security typeOrdinary Share
Fiscal year-endMar 21
Address300 Kimball Drive
CityPARSIPPANY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07054
Phone18624010000
Websitehttps://www.embecta.com/
Ticker SymbolEMBC
IPO dateMar 21, 2022
CEOKurdikar (Devdatt)

Company Executives of Embecta Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
45.58K
+50.12%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
34.01K
-18.45%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
20.34K
-83.88%
Dr. Claire Pomeroy, M.D.
Dr. Claire Pomeroy, M.D.
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%

FAQs

Who are the top five shareholders of Embecta Corp?

The top five shareholders of Embecta Corp are: Mr. Devdatt (Dev) Kurdikar

How many institutions hold shares of Embecta Corp (EMBC)?

As of 2026Q1, 791 institutions hold shares of Embecta Corp, with a combined market value of approximately 59.40M, accounting for 100.13% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -4635325.00.

What is the biggest source of revenue for Embecta Corp?

In 2026Q1, the Pen Needles business generated the highest revenue for Embecta Corp, amounting to 185.50M and accounting for 71.02% of total revenue.